MedPath

A New Surgical Strategy to Protect the Inferior Parathyroid

Not Applicable
Not yet recruiting
Conditions
Thyroid Cancer
Interventions
Procedure: Resection based on "thymus-vascular-inferior parathyroid" complex
Registration Number
NCT05758025
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Brief Summary

The incidence of temporary hypoparathyroidism after thyroid surgery is 14%-60%, and the incidence of permanent hypoparathyroidism is 4%-11%. The protection of parathyroids has always been the focus and difficulty of thyroid surgery. The anatomical position of the superior parathyroids is relatively fixed, and can be preserved in situ easily; while the anatomical position of inferior parathyroids varies greatly between patients. It is always difficult to look for, identify, and protect them. Concepts such as thyro-thymic ligament and "thymus-vascular-inferior parathyroid plane" were raised to help identify the inferior parathyroids. We found that this surgical strategy can protect inferior parathyroids in situ effectively in our retrospective studies. Thus, we are going to carry out a prospective study to compare the new method and the traditional method of thyroidectomy, to see if more inferior parathyroids can be protected in situ through the new surgical strategy.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
506
Inclusion Criteria
  • initial thyroid surgery; thyroidectomy with/without central lymph node dissection
Exclusion Criteria
  • coexisting parathyroid disease; need lateral neck dissection; history of radio-iodine ablation treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Resection based on "thymus-vascular-inferior parathyroid" complexResection based on "thymus-vascular-inferior parathyroid" complex-
Primary Outcome Measures
NameTimeMethod
Primary outcomePostoperative day 1

the incidence of hypothyroidism

Secondary Outcome Measures
NameTimeMethod
Secondary outcomePostoperative day 1

the incidence of parathyroid hormone reduced greater than 50% than parathyroid hormone level before surgery

Trial Locations

Locations (1)

Second Affiliated Hospital Zhejiang University School of Medicine

🇨🇳

Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath